AstraZeneca PLC (AZN) — Capital Reinvestment Ratio
AstraZeneca PLC (AZN) has a Capital Reinvestment Ratio of 0.55x as of December 2025, meaning it reinvests 1% of its operating cash flow (GBX2.34 Billion) in capital expenditures (GBX1.29 Billion). See AstraZeneca PLC net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
AstraZeneca PLC Capital Reinvestment Ratio (1990–2025)
This chart tracks AstraZeneca PLC's Capital Reinvestment Ratio across 36 annual periods. Check AZN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for AstraZeneca PLC (1990–2025)
Year-by-year Capital Reinvestment Ratio for AstraZeneca PLC from 1990 to 2025. For live market cap and broader valuation context, see AstraZeneca PLC market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.41x | GBX14.57 Billion | GBX5.91 Billion | ▲ +4.8% |
| 2024 | 0.39x | GBX11.86 Billion | GBX4.59 Billion | ▲ +5.9% |
| 2023 | 0.37x | GBX10.35 Billion | GBX3.78 Billion | ▲ +39.3% |
| 2022 | 0.26x | GBX9.81 Billion | GBX2.57 Billion | ▼ -29.0% |
| 2021 | 0.37x | GBX5.96 Billion | GBX2.20 Billion | ▼ -32.1% |
| 2020 | 0.54x | GBX4.80 Billion | GBX2.61 Billion | ▼ -34.5% |
| 2019 | 0.83x | GBX2.97 Billion | GBX2.46 Billion | ▲ +58.2% |
| 2018 | 0.52x | GBX2.62 Billion | GBX1.37 Billion | ▲ +15.7% |
| 2017 | 0.45x | GBX3.58 Billion | GBX1.62 Billion | ▼ -18.9% |
| 2016 | 0.56x | GBX4.14 Billion | GBX2.31 Billion | ▼ -33.4% |
| 2015 | 0.84x | GBX3.32 Billion | GBX2.79 Billion | ▲ +115.1% |
| 2014 | 0.39x | GBX7.06 Billion | GBX2.75 Billion | ▲ +40.2% |
| 2013 | 0.28x | GBX7.40 Billion | GBX2.06 Billion | ▼ -58.2% |
| 2012 | 0.66x | GBX6.95 Billion | GBX4.62 Billion | ▲ +300.9% |
| 2011 | 0.17x | GBX7.82 Billion | GBX1.30 Billion | ▼ -26.8% |
| 2010 | 0.23x | GBX10.68 Billion | GBX2.42 Billion | ▼ -10.0% |
| 2009 | 0.25x | GBX11.74 Billion | GBX2.96 Billion | ▼ -45.5% |
| 2008 | 0.46x | GBX8.74 Billion | GBX4.04 Billion | ▲ +106.7% |
| 2007 | 0.22x | GBX7.51 Billion | GBX1.68 Billion | ▲ +28.4% |
| 2006 | 0.17x | GBX7.69 Billion | GBX1.34 Billion | ▲ +19.9% |
| 2005 | 0.15x | GBX6.74 Billion | GBX979.00 Million | ▲ +113.1% |
| 2004 | 0.07x | GBX4.87 Billion | GBX332.00 Million | ▼ -81.8% |
| 2003 | 0.38x | GBX3.42 Billion | GBX1.28 Billion | ▲ +35.4% |
| 2002 | 0.28x | GBX4.83 Billion | GBX1.34 Billion | ▼ -66.8% |
| 2001 | 0.84x | GBX2.71 Billion | GBX2.26 Billion | ▲ +33.7% |
| 2000 | 0.63x | GBX2.34 Billion | GBX1.46 Billion | ▼ -79.4% |
| 1999 | 3.03x | GBX908.55 Million | GBX2.75 Billion | ▲ +215.4% |
| 1998 | 0.96x | GBX879.74 Million | GBX844.88 Million | ▼ -5.0% |
| 1997 | 1.01x | GBX747.21 Million | GBX755.47 Million | ▲ +24.7% |
| 1996 | 0.81x | GBX787.75 Million | GBX638.76 Million | ▲ +10.2% |
| 1995 | 0.74x | GBX585.64 Million | GBX431.11 Million | ▼ -6.5% |
| 1994 | 0.79x | GBX625.36 Million | GBX492.47 Million | ▲ +20.0% |
| 1993 | 0.66x | GBX705.58 Million | GBX462.99 Million | ▼ -66.7% |
| 1992 | 1.97x | GBX206.27 Million | GBX406.47 Million | ▲ +158.3% |
| 1991 | 0.76x | GBX505.22 Million | GBX385.46 Million | ▲ +13.9% |
| 1990 | 0.67x | GBX806.30 Million | GBX540.10 Million | — |